Related Experiment Video
Updated: Aug 23, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Aceruloplasminemia presenting with microcytic anemia in a Turkish boy due to a novel pathogenic variant
Veysel Gok1, Alper Ozcan1, Sinem Ozer2
1Department of Pediatrics, Division of Pediatric Hematology and Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Abstract:
Aceruloplasminemia inherited autosomal recessively in the ceruloplasmin gene is a progressive disease with iron accumulation in various organs such as the brain, liver, pancreas, and retina. Ceruloplasmin gene encodes ceruloplasmin protein, which has ferroxidase activity and is involved in copper and iron metabolism. Progressive neurotoxicity, retinopathy, and diabetes may develop in about 40-60 decades. In addition, microcytic anemia accompanied by high ferritin and low ceruloplasmin level that develop at earlier ages can be first manifestation. Iron chelation may be utilized in the treatment to reduce the toxicity. Early diagnosis and treatment may delay the onset of symptoms. A 14-year-old male patient was followed up with microcytic anemia since an eight-years old. Anemia was accompanied by microcytosis, high ferritin, and low copper and ceruloplasmin levels. A novel homozygous c.690delG variant was detected in ceruloplasmin by whole exome sequencing. Clinical, laboratory and imaging findings of the patient demonstrated aceruloplasminemia. We present a boy with persistent microcytic anemia of the first manifestation at the age of eight, as the youngest case of aceruloplasminemia in the literature. Thereby, aceruloplasminemia should be kept in mind in the etiology of microcytic anemia whose cause couldn't found in childhood.
Insights
Aceruloplasminemia is a rare genetic disorder causing iron buildup in organs. This case highlights microcytic anemia as an early sign, emphasizing the need for early diagnosis in children.
Area of Science:
- Genetics
- Neuroscience
- Metabolic Disorders
Background:
- Aceruloplasminemia is an autosomal recessive disorder affecting iron and copper metabolism, linked to the ceruloplasmin gene.
- It leads to progressive iron accumulation in organs like the brain, liver, and retina, causing neurotoxicity, retinopathy, and diabetes.
Observation:
- A 14-year-old male presented with persistent microcytic anemia since age eight, characterized by microcytosis, elevated ferritin, and low ceruloplasmin and copper levels.
- Whole exome sequencing identified a novel homozygous c.690delG variant in the ceruloplasmin gene.
Findings:
- The patient's clinical, laboratory, and imaging findings confirmed a diagnosis of aceruloplasminemia.
- This case represents the youngest documented patient with aceruloplasminemia, with initial symptoms appearing at age eight.
Implications:
- Microcytic anemia unresponsive to standard treatments should prompt consideration of aceruloplasminemia in pediatric patients.
- Early diagnosis and iron chelation therapy may potentially delay symptom onset and progression of this rare genetic disease.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022